Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study

The safety and efficacy of ivermectin for the prevention and treatment of COVID-19 are still controversial topics. From August to November 2021, we conducted a double-blinded, randomized controlled trial at Siriraj Hospital, Thailand. Eligible participants were adults ≥ 18 years with suspected COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Angkasekwinai, Nasikarn, Rattanaumpawan, Pinyo, Chayakulkeeree, Methee, Phoompoung, Pakpoom, Koomanachai, Pornpan, Chantarasut, Sorawit, Wangchinda, Walaiporn, Srinonprasert, Varalak, Thamlikitkul, Visanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219629/
https://www.ncbi.nlm.nih.gov/pubmed/35740202
http://dx.doi.org/10.3390/antibiotics11060796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219629/
https://www.ncbi.nlm.nih.gov/pubmed/35740202
http://dx.doi.org/10.3390/antibiotics11060796

Ejemplares similares